yeah but the order with lonza would have to be for them to build us a dedicated facility.
there is is an article written with the help of lonza about the manufacturing economics. very technical but explains the cost of goods and limitations in production , in relation to the number and size of reactors required, the handling requirements of having so many reactors to achieve certain numbers of doses per year at certain cell densities using existing expansion technologies.
from the charts in the article i think we can say that without significant investment there won't be enough to go around. considering there are 5m hf patients in usa and 500k new diagnosis per year.
yeah but the order with lonza would have to be for them to build...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |